Drugs Made In America Acquisition II Corp. (DMII)
Market Open
11 Sep, 14:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
10. 18
+0.01
+0.0924%
$
647.83M Market Cap
- P/E Ratio
- Div Yield
3 Volume
- Eps
$ 10.17
Previous Close 
Want to track DMII and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Drugs Made In America Acquisition II Corp. (DMII) Statistics
Valuation metrics
Market Cap 647.83M
Enterprise value 5.83M
Trailing P/E (ttm) 0.39
Forward P/E -
PEG ratio 0
Price/Sales (ttm) -
Price/Book (mrq) 0.01
Enterprise Value/Revenue -
Enterprise Value/EBITDA -4.36
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 144.54K
Average volume (90 days) 90.13K
Price summary
52-Week low 9.86
52-Week high 10.21
Beta -
50-Day moving average 10.11
200-Day moving average 10.03
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets 0.03%
Return on equity 0.03%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.26
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 0.34%
Book value per share (mrq) 9.92
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
